NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
19/10/2021
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Snapshot rápido
CAREFUSION
ST13
US500000077656286Classe
Pedido
Registro
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Tipo de processo
Eventos registrados
Atualização mais recente
Classificação
Tipo de marca
Classes Nice
Data de depósito
Data de registro
Data de expiração
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
Última transação
Escritório responsável
Código da situação
Cadastro oficial
Fundamento do pedido
Primeiro uso
Primeiro uso no comércio
Código do desenho
Tipo de titular
Localização do titular
Examinador
Unidade examinadora
Localização atual
Titulares
Representantes
CAREFUSION CORPORATION
Classes Nice
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 5
Antimicrobials for dermatological and medical use, namely, solutions, creams, gels and lotions
Classe 9
Automatic medication dispensing machines and accessories therefore, namely, access controlled cabinets specially adapted for use with automatic medication dispensing machines, computer hardware, software and instructional manuals sold as a unit therewith for computerized point of use, storage, tracking and data collection; fluid flow rate meters; ammeters; computer programs for controlling and monitoring fluid flow and detecting obstructions to fluid flow in the field of intravenous and respiratory care; computer programs for capturing, storing, integrating and presenting data for patient care management; software for use at the point of care facilities, namely, critical care and ambulatory care for storage tracking of medical equipment, medications, and hospital supplies and data collection for critical care facilities; infusion systems computer servers; surgical instrument tracking software; remote controls for medical equipment, namely, infusion pumps, [ ventilators, ] and secured medication dispensing machines and inventory management systems and remote viewing software; software to integrate physiological monitoring devices and instructional manuals sold as a unit; software for analyzing physiological data and instructional manuals sold as a unit
Classe 10
Medical devices, namely, intravenous fluid monitors; medical instruments and equipment, namely, infusion pumps and controllers; medical instruments and equipment, namely, [ ventilators ] and controllers for patient care; medical apparatus, namely, clinical vital sign measurement instruments; surgical instruments for use in general surgery; medical fluid administration sets comprised primarily of tubes, valves, luer fittings, vial access devices, syringes, and IV stands; instrument sterilization units for medical instruments and for medical purposes; [ sleep, pulmonary and neurology related medical diagnostic machines formulated specifically for the respiratory care market; ] disposable, single use, sterile medical devices used in interventional and surgical procedures, namely, acute para/thoracentesis drainage procedures, bone marrow biopsies, soft tissue biopsies, lumbar puncture, mylogram, arthrogram, OB/Gyn procedures, chronic drainage procedures, and vertebral augmentation procedures; hand-held ultrasonic doppler devices for obstetric and vascular evaluation, namely, remote controls and software for use therewith, sold as a unit in the nature of remote viewing software, software to integrate physiological monitoring devices, and software for analyzing physiological data; physiological monitoring, diagnostic and screening equipment and devices for medical purposes, namely, pulmonary function testing devices and exercise physiology measurement devices; medical diagnostic and screening audiological equipment, namely, audiometers, middle-ear analyzers, otoacoustic emissions and auditory brainstem response devices; and disposable and re-usable medical supplies, namely, electrodes, needles, probes and transducers used in connection therewith; medical apparatus, namely, metered infusion pumps for intravenous patient care
Classe 11
[ Ventilators being interior environmental control apparatus for controlling airflow in hospital rooms for critical patient care ]
Classe 37
[ Installation and repair of electronic medical equipment; hospital room wiring installation for diagnostic and monitoring equipment and related structured wiring; consulting on the installation of computer networks ]
Classe 41
[ clinical education services, namely, providing mentoring, tutoring, classes, seminars and workshops in the fields of oncology, interventional procedures, malignant pleural effusions, and vertebral augmentation; medical training and teaching ]
Classe 42
[ Pharmaceutical research services, namely, research services in connection with data collection and analysis of pharmaceuticals ]
Classe 44
[ Leasing and rental of medical instruments, equipment and accessories; medical services, namely, medical analysis services relating to the treatment of persons, and collection and analysis of data in medical care facilities for medical diagnostic and treatment purposes ]
Histórico de despachos e eventos da marca no USPTO.
64 publicações encontradas
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
19/10/2021
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
19/10/2021
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
19/10/2021
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
28/09/2021
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
09/09/2021
TEAS SECTION 8 & 9 RECEIVED
07/09/2021
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
06/09/2020
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/04/2019
REGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/04/2019
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
17/11/2017
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
17/11/2017
POST REGISTRATION ACTION MAILED - SEC. 8 & 15
10/10/2017
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
30/09/2017
TEAS SECTION 8 & 15 RECEIVED
31/08/2017
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
29/08/2017
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
29/08/2017
REGISTERED-PRINCIPAL REGISTER
06/09/2011
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/08/2011
LAW OFFICE REGISTRATION REVIEW COMPLETED
02/08/2011
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
07/07/2011
TEAS/EMAIL CORRESPONDENCE ENTERED
07/07/2011
CORRESPONDENCE RECEIVED IN LAW OFFICE
07/07/2011
ASSIGNED TO LIE
06/07/2011
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/06/2011
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/06/2011
NON-FINAL ACTION E-MAILED
01/06/2011
SU - NON-FINAL ACTION - WRITTEN
01/06/2011
STATEMENT OF USE PROCESSING COMPLETE
23/05/2011
USE AMENDMENT FILED
18/05/2011
TEAS STATEMENT OF USE RECEIVED
18/05/2011
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
30/11/2010
SOU EXTENSION 1 GRANTED
29/11/2010
CASE ASSIGNED TO INTENT TO USE PARALEGAL
26/11/2010
SOU EXTENSION 1 FILED
15/11/2010
SOU TEAS EXTENSION RECEIVED
15/11/2010
NOA MAILED - SOU REQUIRED FROM APPLICANT
25/05/2010
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
30/03/2010
PUBLISHED FOR OPPOSITION
30/03/2010
LAW OFFICE PUBLICATION REVIEW COMPLETED
19/02/2010
ASSIGNED TO LIE
19/02/2010
APPROVED FOR PUB - PRINCIPAL REGISTER
25/01/2010
EXAMINER'S AMENDMENT ENTERED
21/01/2010
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
21/01/2010
EXAMINERS AMENDMENT E-MAILED
21/01/2010
EXAMINERS AMENDMENT -WRITTEN
21/01/2010
NOTIFICATION OF FINAL REFUSAL EMAILED
29/10/2009
FINAL REFUSAL E-MAILED
29/10/2009
FINAL REFUSAL WRITTEN
29/10/2009
TEAS/EMAIL CORRESPONDENCE ENTERED
21/10/2009
CORRESPONDENCE RECEIVED IN LAW OFFICE
21/10/2009
TEAS RESPONSE TO OFFICE ACTION RECEIVED
21/10/2009
NOTIFICATION OF NON-FINAL ACTION E-MAILED
16/09/2009
NON-FINAL ACTION E-MAILED
16/09/2009
NON-FINAL ACTION WRITTEN
16/09/2009
TEAS/EMAIL CORRESPONDENCE ENTERED
10/09/2009
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/09/2009
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/09/2009
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
10/06/2009
NOTIFICATION OF NON-FINAL ACTION E-MAILED
14/04/2009
NON-FINAL ACTION E-MAILED
14/04/2009
NON-FINAL ACTION WRITTEN
14/04/2009
ASSIGNED TO EXAMINER
08/04/2009
NOTICE OF PSEUDO MARK MAILED
30/01/2009
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
29/01/2009
Proteção contínua da sua marca
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.